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Due to the poor aqueous solubility of retinoids, evolution has tuned their binding to cellular 
proteins to address specialized physiological roles by modulating uptake, storage, and delivery to 
specific targets. With the aim to disentangle the structure-function relationships in these proteins 
and disclose clues for engineering selective carriers, the binding mechanism of the two most 
abundant retinol-binding isoforms was explored by using enhanced sampling molecular 
dynamics simulations and surface plasmon resonance. The distinctive dynamics of the entry 
portal site in the holo species was crucial to modulate retinol dissociation. Remarkably, this 
process is controlled at large extent by the replacement of Ile by Leu in the two isoforms, thus 
suggesting that a fine control of ligand release can be achieved through a rigorous selection of 









Retinol is essential for many physiological processes like cell growth and differentiation, 
morphogenesis, and vision.1 However, the poor aqueous solubility makes the assistance of 
plasma and cellular binding proteins necessary for the delivery to target tissues, and the uptake 
and transport to specific partners in the cell.2-4 In fact, the efficient transport of hydrophobic 
molecules has been solved by evolution through selection of specialized binding proteins, such 
as the calycin and SEC14-like superfamilies.5-7 Although amino acid homology between the 
members of this widely distributed protein family is typically low, they share a similar β-barrel 
fold.8,9 Many of these proteins contain only this structural domain and can presumably be 
involved in transport of hydrophobic compounds, while others may have other domains, 
reflecting the involvement in a variety of cellular functions, such as signal transduction and 
regulatory roles. Nevertheless, a precise knowledge of the mechanisms of recognition and 
binding is required to understand the roles in the cell, as illustrated by the ligand exchange 
mechanism that couples transfer of α-tocopherol and phosphatidylinositol phosphate lipids 
between the endosome and plasma membranes.10,11 
 The two most abundant intracellular retinol-binding proteins (CRBP; isoforms I and II) have 
distinct tissue distribution and binding affinity for retinol, reflecting the specialized adaptation of 
CRBP-I as retinol storage in the liver, and the uptake of retinol from the intestinal lumen and 
release into the blood by CRBP-II in epithelial cells.4 The impact of residue substitutions selected 
by evolution in tuning the thermodynamics and kinetics of retinol binding to these isoforms is a 
conundrum. Hence, understanding the ability of CRBPs to sequester and protect retinol from the 
cellular milieu, and to direct it to dedicated targets is essential for furthering metabolic 
engineering through selective nanocarriers and for drug discovery in retinoid-related diseases. 12-14  
The structural fold of CRBP-I and II consists of a β-barrel formed by two almost orthogonal 
five-stranded β-sheets (A-E and F-J), and two short helices (αI and αII) inserted between βA and 
βB strands (Figure 1).15 The entry portal site is a crucial element formed by helices αI and αII 
and turns βC-βD and βE-βF that enables retinol to enter into the cavity. Both NMR15-17 and X-ray18 
data show that the binding mode of retinol is highly similar not only in human CRBP-I and II, 
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but also in rat CRBPs.19-22 Despite the high structural identity between rat CRBP-I and II (56% 
residue identity and 70% residue homology), the retinol dissociation constant (KD) for CBRP-I is 
smaller relative to CRBP-II, the ratio between binding affinities varying from ∼100-fold12 
according to NMR measurements to 3.3-fold based on fluorimetric assays.23 At present, it is 
unclear whether the affinity difference between the two isoforms stems from the few residue 
substitutions that line the binding pocket in the interior of the β-barrel (SI Figure S1), or 
alternatively to differences in the dynamics of CRBP-I and II,15 which might affect the 
entry/release of retinol to/from the binding cavity.  
To investigate the binding mechanisms in rat CRBP-I and II and explore their functional 
implications, a detailed analysis of apo and holo forms was performed by combining extended 
atomistic molecular dynamics (MD) simulations and parallel-tempering metadynamics (PT-
metaD). We characterized the conformational flexibility of the two isoforms as well as the free 
energy surfaces for the opening/closing of the portal site in both apo and holo forms, and the 
formation/breaking of interactions between retinol and protein in the holo species. Furthermore, 
surface plasmon resonance (SPR) was used to examine the thermodynamics and kinetics of 
retinol binding. Overall, both theoretical and experimental results provide detailed insight into 
the binding mechanism, disclosing a linkage between retinol binding and the flexibility of the 
entry portal, particularly regarding the methyl isomerism between Ile and Leu in this accessory 




Figure 1. Representation of the retinol-CRBP complex. The structural fold of CRBP consists of 
10 antiparallel β-strands (A-J) and two short α helices (I and II). The regions that define the 
entry portal site are highlighted in yellow. Retinol (RTL) is shown as blue sticks. 
 
The conformational flexibility of apo and holo forms of CRBP-I and II was examined from 
three independent MD simulations (5, 3 and 3 µs) performed for each system, covering a total of 
44 µs. The root-mean square deviation profiles supported the structural stability of the simulated 
systems along the trajectories (SI Figure S2). In both isoforms, the presence of retinol reduced 
the structural fluctuations of the protein, as expected from the interactions formed with residues 
in the binding cavity (Figure 2; see also SI Figures S3-S6). However, the pattern of residue 
fluctuations differed in the two isoforms. While apo-I showed increased fluctuations in loops βE-
βF, βG-βH and at less extent βC-βD, apo-II exhibited larger fluctuations in helices αI-αII and at 
less extent in loops βC-βD and βD-βE (Figure 2A). Remarkably, most of these elements define 
the entry portal site, suggesting that the two isoforms differ in the dynamics of key structural 
elements implicated in the entry/release of retinol to/from the binding cavity.24,25  
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Essential Dynamics (ED) analysis was employed to gain insight into the distinct flexibility of 
CRBP-I and CRBP-II. The analysis was performed for the backbone atoms of residues 7–134 to 
avoid the noise due to the mobile parts at the N- and C-termini. The first essential mode (Figure 
2B) accounted for 15-25% of the entire structural variance, and generally was 2-fold larger than 
the contribution explained by the second mode. The apo systems exhibited larger structural 
deformations, especially in the entry portal site, although helices αI-αII were stiffer in apo-I than 
in apo-II. On the other hand, holo systems were more rigid than their apo forms, as noted in the 
lower extent of the backbone motions. However, the decrease in conformational flexibility of the 
protein backbone did not affect similarly the two isoforms. In fact, the rigidification of the entry 
portal site was more important in holo-I than in holo-II (SI Table S1). At first sight, these results 
seemed to be in contrast with NMR H/F exchange experiments15 that suggested a larger flexibility 
in both apo and holo states of CRBP-II relative to CRBP-I. However, it is worth noting that 
residues in the βE-βF loop of apo-I could not be assigned, while present results reveal that this 
structural element has a crucial influence on the dynamics of the portal site. Indeed, upon 
exclusion of the βE-βF loop in ED analyses, CRBP-II was slightly more flexible than CRBP-I in 
both apo and holo states (SI Table S1 and Figure S7), thus reconciling the experimental findings 




Figure 2. (A) Difference in residue fluctuations (ΔRMSF) observed along 5 μs MD trajectories 
between apo and holo states for (top) CRBP-I and (bottom) II. Highlighted regions correspond to 
structural elements of the entry portal site: helices αI and αII (magenta), loop βC-βD (blue), and 
loop βE-βF (orange). (B) Essential dynamics analysis of (top) CRBP-I and (bottom) II derived 
from the 5 μs MD simulation. Only the first projection of the whole system is shown for apo and 
holo forms.  
 
To estimate the differences in the dynamics of apo and holo systems, the conformational 
entropy was evaluated for the whole system as well as separately for the entry portal site and the 
protein core, formed mainly by the β-barrel, using the procedure by Harris et al (See Supporting 
Information for details).26 As expected, the results (Table 1; see also Table S2 and Figure S8) 
confirmed that holo systems were less flexible than apo ones, and pointed out that the decrease 
in entropy was larger for CRBP-I (0.56 Kcal mol-1 K-1) than for CRBP-II (0.14 Kcal mol-1 K-1). 
Furthermore, the conformational entropy (S∞) obtained for apo-I was larger (by 0.35 Kcal mol-1 K-
1) than for apo-II, whereas the difference between the holo species was reduced to 0.07 Kcal mol-1 
K-1. Noteworthy, the entropy difference between apo-I and apo-II and between holo-I and holo-II 
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was mainly due to the differences in the entry portal site (apo: 0.27 Kcal mol-1 K-1; holo: -0.06 
Kcal mol-1 K-1). Overall, these results confirm that the distinct patterns of conformational 
flexibility between the two isoforms primarily arise from the entry portal site. 
 
Table 1. Entropy (S∞) and entropy difference (ΔS) of the whole protein, and its core and entry 
portal site, determined from the analysis of the 5µs MD trajectory. Values (Kcal mol-1 K-1) 
determined considering only the backbone atoms. 
System Protein[a] Core[b] Portal site[c] 
S∞(apo-I) [d] 2.97 1.76 1.21 
S∞ (holo-I) 2.41 1.59 0.81 
S∞ (apo-II) 2.62 1.68 0.94 
S∞ (holo-II) 2.48 1.61 0.87 
ΔS (apo-I - holo-I) 0.56 0.17 0.38 
ΔS (apo-II - holo-II) 0.14 0.07 0.07 
ΔS (apo-I - apo-II) 0.35 0.08 0.27 
ΔS (holo-I - holo-II) -0.07 -0.02 -0.06 
[a] Residues 7-134. [b] Excluding the structural elements of the entry portal site. [c] Helices αI-αII 
and loops βC-βD and βE-βF. [d] The error of the conformational entropy was estimated from the 
standard deviation of S∞ obtained in the fitting at increasing simulation windows, with an upper 
value of 0.008 Kcal mol-1 K-1 for the whole protein and the portal site, and 0.005 Kcal mol-1 K-1 for 
the protein core. 
 
Since the stiffness of the portal site in holo-I was higher than in holo-II, we hypothesized that 
the difference in binding affinity between CRBP-I and II might arise from a larger residence time 
of retinol in the former isoform. To address this question, PT-metaD was used to evaluate the 
free energy landscape for the opening/closing of the entry portal site in apo and holo systems, 
and the binding/unbinding of retinol to/from the holo systems. In order to take into account the 
larger structural flexibility of the open state compared to the closed one, the free energy change 
for the opening/closing of the entry portal site was estimated by averaging the values determined 
from three separate calculations, each relying on the use of distinct open structures chosen as 
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reference systems (SI Figures S9-S11). The results pointed out that the opening of the portal site 
in the apo state of CRBP-I and II was very similar and close to 5.5 ± 0.2 Kcal mol-1 (Figure 3A). 
However, the presence of retinol in the β-barrel had a marked influence on the opening of the 
portal site in holo-I, as this process was disfavoured by 3.8 Kcal mol-1 compared to apo-I. 
Remarkably, the presence of retinol led to a modest increase in the cost of opening the portal site 
in holo-II (by only 0.7 Kcal mol-1) relative to apo-II. These findings agree with the larger 
decrease in conformational entropy found for CRBP-I relative to CRBP-II upon retinol binding 
(see above and Table 1).  
The analysis of the structures sampled during the opening of the portal site reveals that there is 
a slight rearrangement of retinol in the binding pocket, although the ligand remains trapped in the 
interior of the β-barrel after opening of the loop in both CRBP-I and II (Figure 4). However, 
whereas the rearrangement of retinol occurs in a fast process during the first 100 ns of the loop 
opening for CRBP-II, a slower process that involves a gradual rearrangement of retinol is 
observed for the loop opening in CRBP-I. This suggests the presence of stronger interactions 
between the ligand with the residues of the portal site in this latter isoform, as will be discussed 
later.   
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Figure 3. (A) Free energy surface for the opening/closing of the entry portal site in apo and holo 
forms of CRBP-I and II. Closed and open states are indicated by symbols I and II, respectively. 
Contour lines are drawn every 1.5 Kcal mol-1. Values in the plots are the average of three 
estimates generated by using different reference structures for the open state. (B) Free energy 
surface for the binding/unbinding of retinol from holo-I and holo-II. Bound and unbound states 





Figure 4. RMSD (Å) of retinol along the opening of the portal site in (left) CRBP-I and (right) 
II. The RMSD was determined relative to the arrangement of retinol in the energy-minimized 
structure of holo-I and holo-II species, after alignment of the protein core. The snapshots were 
taken during the 500 ns of the pT-metaD simulation at 300 K. 
  
PT-MetaD simulations were also used to estimate the free energy for retinol binding/unbinding 
from the open state of the two isoforms. Calculations were started from suitably chosen holo 
structures characterized by the presence of a portal site open enough to enable the release of 
retinol from the protein cavity without steric clashes. Similar events were involved in the release 
of retinol from CRBP-I and II (SI Figure S12). Briefly, retinol unbinding involves first the 
breakage of the hydrogen bond formed by the terminal hydroxyl group and subsequent release of 
the polyene tail, which becomes progressively more exposed to water molecules, followed by the 
breakage of the van der Waals interactions with the β-ionone ring, leading to immersion in the 
aqueous environment. The free energy surfaces determined for CRBP-I and II (Figure 3B) 
pointed out that the energetic cost for retinol unbinding is only 1 Kcal mol-1 higher in holo-II. 
Overall, the combination of the free energy estimates obtained for the opening/closing in apo 
and holo states, and the binding/unbinding of retinol from holo species, indicates that the affinity 
of CRBP-I for retinol is 2.4 Kcal mol-1 more favourable relative to CRBP-II (Figure 5). 
Noteworthy, this agrees with the experimentally observed greater affinity of retinol for CRBP-I, 
as the predicted affinity lies between the range of experimental values, which vary from an upper 
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threshold of <∼100-fold12 to a lower limit of 3.3-fold greater affinity for CRBP-I.23 Remarkably, 
our results also revealed that the difference in binding affinity is mainly determined by the 
opening/closure of the entry portal site in the holo state. This suggests that the larger cost of 
opening the holo-I complex cannot be attributed to the interactions formed by the portal site with 
the rest of the protein, as the free energy changes determined for the opening of the portal site in 
the apo species are highly similar in the two isoforms (Figure 5; see also SI Figure S13). 
Therefore, it may be speculated that the interactions formed between retinol and the entry portal 
site in the holo species are more favourable in CRBP-I than in CRBP-II, thus providing a basis to 
justify the larger decrease in conformational flexibility observed upon retinol binding to CRBP-I 
relative to CRBP-II. 
 
Figure 5. Thermodynamic cycle for the opening of the entry portal site for apo states, the 
binding of retinol, and the closure of the portal site in holo systems in (A) CRBP-I and (B) II. 
Values are in Kcal mol-1. 
This assumption was confirmed from the analysis of the interaction energies between retinol 
and the structural elements that define the portal site in holo-I and holo-II (Table 2). Whereas the 
interaction energy with helices αI-αII and loop βC-βD was similar in the two holo systems, the 
interaction of retinol with loop βE-βF was 2.6 Kcal mol-1 more stabilizing in holo-I. Further 
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decomposition into pairwise ligand-residue contributions revealed that the energy difference was 
mainly due to the interactions with Gly77 and Ile78 in CRBP-I, which were 2.1 Kcal mol-1 more 
stabilizing than the interactions with Gly77 and Leu78 in CRBP-II (SI Table S3). In contrast, 
other residue substitutions located in the loop βE-βF contributed less than 0.2 Kcal mol-1, even 
though this can be justified from either the solvent-exposed arrangement of the side chain of 
these residues or the large distance from the mutated residue to retinol. In contrast, residues at 
position 78 (Ile in CRBP-I, Leu in CRBP-II) are located at the top of the loop βE-βF, pointing 
toward the interior of the β-barrel, and form van der Waals contacts with the β-ionone ring and 
the unsaturated chain of retinol (Figure 6). Overall, these results point out that the difference in 
the interaction energy with retinol can be mainly attributed to the conservative mutation of Ile78 
in CRBP-I to Leu78 in CRBP-II, disclosing an unexpected effect related to the methyl isomerism 
between the side chains of these two residues. 
To confirm the impact of the Ile/Leu mutation at position 78 on the binding of retinol to 
CRBP-I and II, SPR was used to characterize the kinetic rate constants for the association (kon) 
and dissociation (koff) of retinol to CRBP-II and its Leu78→Ile single-mutated variant (SI Figures 
S14-S15 and Table S4). The results show that the kon remains essentially unaltered for both 
CRBP-II and the mutated variant (Table 3). However, the koff of retinol is slowed down by a 
factor of ∼2.2 in the mutated protein. The increased residence time originated by the single-point 
mutation Leu78 →Ile agrees with the expected strengthening of the interaction of retinol with the 
mutated residue in CRBP-I (Ile) relative to CRBP-II (Leu), as deduced from the PT-metaD 
simulations and the decomposition analysis presented above (Table 2 and SI Table S3). 
Furthermore, the dissociation constant (KD) is decreased by ∼2.8-fold in the mutated CRBP-II, 




Table 2. Interaction energies (Eint; Kcal mol-1) and its electrostatic (Eele; Kcal mol-1) and van der 
Waals (Evdw) components between retinol and the entry portal site for holo-I and holo-II. 
System[a] Eint Eele Evdw 
holo-I (αI-αII) -10.6 0.2 -10.8 
holo-II (αI-αII) -11.0 -0.4 -10.6 
holo-I (βC-βD) -6.4 0.1 -6.5 
holo-II (βC-βD) -6.0 0.3 -6.3 
holo-I (βE-βF) -6.4 -0.2 -6.2 
holo-II (βE-βF) -3.8 -0.4 -3.4 
[a] Calculations performed for 50 snapshots taken regularly in the last microsecond of the 5μs 
MD simulations. Helices α-I and α-II comprise residues Glu15-Leu37, and loops βC-βD and 
βE-βF involve residues Ser55-Asn59 and Glu73-Cys/Val83, respectively. 
 
 
Figure 6. Representation of (A) holo-I and (B) holo-II. Residues in the βE-βF loop with higher 
contribution to the interaction energy with retinol (RTL) are highlighted as spheres, and retinol is 
shown as sticks (β-sheets C and D are not shown for the sake of clarity). 
 
Table 3. Kinetic rate constants (kon, M-1 s-1; koff, s-1) and dissociation constant (KD; M) for the 
interactions between retinol and CRBP-II and its Leu78→Ile single-mutated variant. 
CRBP-II kon koff KD 
wild type 241.5 17.9 10-3 7.4 10-5 
Leu78→Ile 312.4 8.1 10-3 2.6 10-5 
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The selectivity of different members of cytosolic binding proteins toward distinct retinoid-like 
compounds has been related to the presence of specific residues in the β-barrel.27,28 Furthermore, 
other studies have identified hydrophobic contacts between ligands and structural elements of the 
mobile gate in SEC14-like family members.29-31 Present results, however, point out that a 
seemingly minor chemical change related to the methyl isomerism between Ile and Leu at the 
portal site modulates the binding properties of retinol between closely related CRBP isoforms. 
The net effect is the enhanced free energy penalty associated to the closed→open transition, 
which would disfavour the release of the ligand and increase the residence time of retinol in the 
interior of the β-barrel. Noteworthy, the affinity for the two isoforms is finely modulated by the 
differential interaction of the β-ionone unit of retinol with the residue (Ile/Leu) at the top of the 
loop βE-βF, suggesting an unexpected role of the methyl isomerism between the two similar 
residues.  
From a functional point of view, these results unveil a subtle regulation mechanism that 
underlies the distinct physiological role of the two isoforms. In enterocytes, CRBP-II plays an 
important, but not essential, role in assisting the transient exchange of retinol from the intestinal 
lumen to the lymph, making it necessary to have an efficient delivery system. In contrast, CRBP-
I is highly expressed in hepatic cells, where it participates in the storage of retinol and controls 
its mobilization to ensure a steady supply in the blood plasma. Therefore, the strengthened 
interaction of retinol with the β-barrel lid may have evolved as a mechanism to self-regulate 
long-term retinol mobilization subject to specific requirements of active retinoid metabolites to 
the target cells without being affected by the fluctuations of the dietary intake.  
Finally, these findings demonstrate that conservative changes in specific residues at remote 
sites distinct from the binding pocket, which should not alter the gross structural and 
physicochemical features of the protein, may result in a fine-tuning of the ligand's binding 
properties. Thus, a thoughtful selection of residue variations may be instrumental for engineering 
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